Zydus Lifesciences Limited (BOM: 532321)
India
· Delayed Price · Currency is INR
985.75
-9.30 (-0.93%)
At close: Jan 21, 2025
Zydus Lifesciences Revenue
Zydus Lifesciences had revenue of 52.37B INR in the quarter ending September 30, 2024, with 19.87% growth. This brings the company's revenue in the last twelve months to 214.84B, up 14.42% year-over-year. In the fiscal year ending March 31, 2024, Zydus Lifesciences had annual revenue of 195.47B with 13.40% growth.
Revenue (ttm)
214.84B
Revenue Growth
+14.42%
P/S Ratio
n/a
Revenue / Employee
7.98M
Employees
26,921
Market Cap
992.05B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 195.47B | 23.10B | 13.40% |
Mar 31, 2023 | 172.37B | 21.28B | 14.08% |
Mar 31, 2022 | 151.10B | 7.06B | 4.90% |
Mar 31, 2021 | 144.04B | 1.50B | 1.06% |
Mar 31, 2020 | 142.53B | 10.88B | 8.26% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,398.38B |
Tata Consultancy Services | 2,520.82B |
HDFC Bank | 2,761.06B |
Bharti Airtel | 1,554.78B |
ICICI Bank | 1,638.51B |
Infosys | 1,635.60B |
State Bank of India | 3,360.28B |
ITC Limited | 751.35B |